A study on drug utilization pattern and possible drug - drug interactions amoung patients with chronic obstructive pulmonary disease in a tertiary care hospital

Registration ID: IJNRD_226634

Published ID: IJNRDTH00186

: http://doi.one/10.1729/Journal.41126

Dheeraj Kumar Bhakat, Archa S Kumar, Kabilan R, Prithvika Wagle

Drug utilisation Pattern, COPD, Drug-drug interactions.

Introduction: Drug Utilization studies is the strongest tool for promoting rational use of drugs in the society. Drug utilization studies help to update clinical medicine. The mortality and morbidity rate are high in COPD patients. In this field there is lack of Drug utilization study. In this study we made an attempt to assess the current prescribing pattern with the WHO prescribing indicators to check whether the prescription pattern followed WHO guidelines and also, we assessed the possible drug-drug interactions in drugs used in the COPD treatment. Methods: A retrospective observational analysis of 300 patients who was admitted in general medicine and pulmonary department was done over a period of 6 months, we recorded the cases from 2016 January to 2020 September and those who met the inclusion criteria. The study was carried out at Sagar Hospital, Kumaraswamy layout, Bengaluru. Drug-Drug interactions were analysed using Lexicomp software. The prescription was analysed using descriptive statistics and the results were expressed in percentage. Results: Out of 300 patients, 102 (34 %) were female and 198 (66%) were found to be male. Majority of patients (42.3%) were above the age of 70 and the least (2.3 %) was found to be below the age of 40. The majority of patients (31%) had only one comorbid condition. Total number of COPD drugs prescribed was found to be 1554. Most frequently used class of drug was short acting beta 2 agonist (90.3%), followed by inhaled corticosteroids (87%), antibiotics (85.6%), short acting muscarinic antagonist (74.6%). Most of the drugs were prescribed by brand name and only 5.4% were prescribed by generic name. The percentage of drugs prescribed from WHO EDL was 49.4%. We found out a total number of 135 drug-drug interactions, in that 59% was found to be Pharmacodynamic interactions and 41 % to be Pharmacokinetic interactions. The severity assessment of DDIs in our study showed that most of interactions were moderate 117(86.6%) followed by major 15(11.2%) and minor 3(2.2%) interactions. Conclusions: This study concludes that prescribing patterns did not follow WHO core prescribing indicators with polypharmacy being common, the concept of generic name prescribing was negligible and reduced prescription from WHO-EDL. Before prescribing medicines, using computer-assisted drug interaction software can help us discover these potential drug-drug interactions, which can assist us to detect and prevent DDI.

Published Paper   E-Certificate

Dheeraj Kumar Bhakat, Archa S Kumar, Kabilan R, & Prithvika Wagle (August-2024). A study on drug utilization pattern and possible drug - drug interactions amoung patients with chronic obstructive pulmonary disease in a tertiary care hospital . INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT, 9(8), 141-242. http://doi.one/10.1729/Journal.41126

Volume 9 Issue 8, August-2024

Pages : 141-242

Paper Reg. ID: IJNRD_226634

Published Paper Id: IJNRDTH00186

Downloads: 000122038

Research Area: Medical Science

Author Type: Indian Author

Country: Dehradun, Uttarakhand, India

Published Paper PDF: https://ijnrd.org/papers/IJNRDTH00186.pdf

Published Paper URL: https://ijnrd.org/viewpaperforall?paper=IJNRDTH00186

Crossref DOI: http://doi.one/10.1729/Journal.41126

Journal Name: INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT(IJNRD)

UGC CARE JOURNAL PUBLICATION | ISSN: 2456-4184 | IMPACT FACTOR: 8.76 Calculated By Google Scholar | ESTD YEAR: 2016

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 8.76 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Publisher: IJNRD (IJ Publication) Janvi Wave | IJNRD.ORG | IJNRD.COM | IJPUB.ORG

© 2025 — Authors hold the copyright of this article. This work is licensed under a Creative Commons Attribution 4.0 International License. and The Open Definition.

You are free to share, adapt, and redistribute the material, provided proper credit is given to the original author. 🛡️ Disclaimer: The content, data, and findings in this article are based on the authors’ research and have been peer-reviewed for academic purposes only. Readers are advised to verify all information before practical or commercial use. The journal and its editorial board are not liable for any errors, losses, or consequences arising from its use.

Call For Paper - Volume 10 | Issue 11 | November 2025

IJNRD is a Scholarly Open Access, Peer-Reviewed, Refereed, and UGC CARE Journal Publication with a High Impact Factor of 8.76 (calculated by Google Scholar & Semantic Scholar | AI-Powered Research Tool). It is a Multidisciplinary, Monthly, Low-Cost, and Transparent Peer Review Journal Publication that adheres to the UGC CARE 2025 Peer-Reviewed Journal Policy and aligns with Scopus Journal Publication standards to ensure the highest level of research quality and credibility.

IJNRD offers comprehensive Journal Publication Services including indexing in all major databases and metadata repositories, Digital Object Identifier (Crossref DOI) assignment for each published article with additional fees, citation generation tools, and full Open Access visibility to enhance global research reach and citation impact.

The INTERNATIONAL JOURNAL OF NOVEL RESEARCH AND DEVELOPMENT (IJNRD) aims to advance applied, theoretical, and experimental research across diverse academic and professional fields. The journal promotes global knowledge exchange among researchers, developers, academicians, engineers, and practitioners, serving as a trusted platform for innovative, peer-reviewed journal publication and scientific collaboration.

Indexing Coverage: Google Scholar, SSRN, ResearcherID-Publons, Semantic Scholar (AI-Powered Research Tool), Microsoft Academic, Academia.edu, arXiv.org, ResearchGate, CiteSeerX, ResearcherID (Thomson Reuters), Mendeley, DocStoc, ISSUU, Scribd, and many other recognized academic repositories.

How to submit the paper?

By Our website

Click Here to Submit Paper Online

By Mail

Send your paper to editor@ijnrd.org

You can now publish your research in IJNRD. IJNRD is a Transparent Peer-Reviewed Open Access Journal Publication (Refereed Journal), aligning with New UGC and UGC CARE recommendations.

For more details, refer to the official notice: UGC Public Notice

Submit Paper Online

Important Dates for Current issue

Paper Submission Open For: November 2025

Current Issue: Volume 10 | Issue 11 | November 2025

Impact Factor: 8.76

Last Date for Paper Submission: Till 30-Nov-2025

Notification of Review Result: Within 1-2 Days after Submitting paper.

Publication of Paper: Within 01-02 Days after Submititng documents.

Frequency: Monthly (12 issue Annually).

Journal Type: IJNRD is an International Peer-reviewed, Refereed, and Open Access Journal with Transparent Peer Review as per the new UGC CARE 2025 guidelines, offering low-cost multidisciplinary publication with Crossref DOI and global indexing.

Subject Category: Research Area

Call for Paper: More Details

Approval, Licenses and Indexing: More Details